TH125697A - Ramipril solid pharmaceutical formula And amlodipine basilate and its formulation - Google Patents
Ramipril solid pharmaceutical formula And amlodipine basilate and its formulationInfo
- Publication number
- TH125697A TH125697A TH1201004263A TH1201004263A TH125697A TH 125697 A TH125697 A TH 125697A TH 1201004263 A TH1201004263 A TH 1201004263A TH 1201004263 A TH1201004263 A TH 1201004263A TH 125697 A TH125697 A TH 125697A
- Authority
- TH
- Thailand
- Prior art keywords
- amlodipine
- basilate
- ramipril
- solid pharmaceutical
- stable
- Prior art date
Links
- HTIQEAQVCYTUBX-UHFFFAOYSA-N Amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 title claims abstract 5
- 229960000528 amlodipine Drugs 0.000 title claims abstract 5
- 239000007787 solid Substances 0.000 title claims abstract 5
- HDACQVRGBOVJII-JBDAPHQKSA-N Ramipril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](C[C@@H]2CCC[C@@H]21)C(O)=O)CC1=CC=CC=C1 HDACQVRGBOVJII-JBDAPHQKSA-N 0.000 title claims abstract 3
- 229960003401 Ramipril Drugs 0.000 title claims abstract 3
- 239000000203 mixture Substances 0.000 title claims 3
- 238000009472 formulation Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract 3
- 229940079593 drugs Drugs 0.000 claims abstract 3
- 239000000654 additive Substances 0.000 claims abstract 2
- 239000008187 granular material Substances 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 239000005426 pharmaceutical component Substances 0.000 claims 1
- 239000002356 single layer Substances 0.000 claims 1
- 239000000470 constituent Substances 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 230000000996 additive Effects 0.000 abstract 1
- 239000000546 pharmaceutic aid Substances 0.000 abstract 1
Abstract
DC60 (22/08/55) การประดิษฐ์นี้มุ่งเน้นไปยังองค์ประกอบทางเภสัชกรรมชนิดของแข็งที่มีขนาดยาคงที่ และมี ความเสถียร ที่ประกอบรวมด้วย แรมิพริล, แอมโลไดพีน เบซิเลท และสารเติมเนื้อยาซึ่งเป็นที่ยอมรับ ในทางเภสัชกรรม และการเตรียมของสารนั้น การประดิษฐ์นี้มุ่งเน้นไปยังองค์ประกอบทาเภสัชกรรมชนิดของแข็งที่มีขนาดยาคงที่ และมี ความเสถียร ที่ประกอบรวมด้วย แรมิพริล,แอมโลไดพีน และสารเติมเนื้อยาซึ่งเป็นที่ยอมรับ ในทางเภสัชกรรม และการเตรียมของสารนั้น สิทธิบัตรยา DC60 (22/08/55) This invention focuses on the stable and stable dosed solid pharmaceutical constituents that include ramepril, amlodipine basilate and A well-accepted drug additive In pharmaceutical And preparation of that substance This invention focuses on the stable and stable dosed solid pharmaceutical constituents that include: Ramipril, amlodipine And an acceptable drug-based additive In pharmaceutical And the preparation of that substance, the patent of the drug
Claims (3)
Publications (2)
Publication Number | Publication Date |
---|---|
TH125697B TH125697B (en) | 2013-07-25 |
TH125697A true TH125697A (en) | 2013-07-25 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX340591B (en) | Immediate release formulations and dosage forms of gamma-hydroxybutyrate. | |
EA201101192A1 (en) | PHARMACEUTICAL COMPOSITION, INCLUDING DERIVATIVES GLUCOPIRANZYDHYPHENILMETHANE, PHARMACEUTICAL DOSED FORM, CONTAINING INDICATED DERIVATIVES, METHOD OF THEIR RECEIVING APPLICATIONS | |
IL208832A (en) | 3-aminocarbazole compounds, pharmaceutical compositions containing them, preparation methods thereof and use thereof in the production of drugs | |
WO2012032209A3 (en) | Pharmaceutical composition for the treatment of dry eye | |
EP4233978A3 (en) | Oral delivery of active drug substances | |
BRPI0814666A2 (en) | pharmaceutical composition for oral administration, use of a formulation. process for preparing a solid dosage form, and, solid dosage form | |
EA201590805A1 (en) | COMPOSITION WITH IMMEDIATE AND PROLONGED DELIVERY | |
EA201591830A1 (en) | PHARMACEUTICAL COMPOSITIONS, INCLUDING EVEROLIMUS | |
UA103025C2 (en) | Solid pharmaceutical formulation with delayed release | |
MX358636B (en) | Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof. | |
PH12015500823A1 (en) | Modified release formulations for oprozomib | |
EA201400737A1 (en) | DELIVERY SYSTEM ON THE BASIS OF A PELLET SET WITH IMMEDIATE release of an ACTIVE SUBSTANCE | |
EA201401309A1 (en) | PHARMACEUTICAL COMPOSITION FOR INHALATION, CONTAINING ACHYDINE, AND ITS APPLICATION | |
EA201300857A1 (en) | PYRAZOLES AS AN ANTAGONISTS CRTH2 | |
PH12014502407A1 (en) | New alfentanil composition for the treatment of acute pain | |
EP2682129A3 (en) | Compositions Comprising Muscarinic Receptor Antagonist and Glucose Anhydrous | |
EA201390911A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING PLANT ACTIVE SUBSTANCE | |
WO2011128634A3 (en) | Over the counter pharmaceutical compositions | |
TH125697A (en) | Ramipril solid pharmaceutical formula And amlodipine basilate and its formulation | |
DK2146951T3 (en) | Novel agonist ligands of RAR receptors and their use in human medicine and cosmetics | |
TH125697B (en) | Ramipril solid pharmaceutical formula And amlodipine basilate and its formulation preparation | |
EP2682103A3 (en) | Compositions Comprising Muscarinic Receptor Antagonist and Sorbitol | |
WO2016014680A3 (en) | Oral transmucosal compositions including aromatase inhibitors for low testosterone levels in men | |
WO2011128628A3 (en) | Gelled oral pharmaceutical compositions | |
BR112014014289A2 (en) | diabetes treatment method, formulation for oral administration, composition, and use of any or more of the phenoxypyrimidinone and insulin compounds |